Prediction of binding affinities for TIBO inhibitors of HIV-1 reverse transcriptase using Monte Carlo simulations in a linear response method

被引:93
|
作者
Smith, RH [1 ]
Jorgensen, WL
Tirado-Rives, J
Lamb, ML
Janssen, PAJ
Michejda, CJ
Smith, MBK
机构
[1] Western Maryland Coll, Dept Chem, Westminster, MD 21157 USA
[2] NCI, ABL, Basic Res Program, Frederick Res & Dev Ctr, Ft Detrick, MD 21702 USA
[3] Yale Univ, Dept Chem, New Haven, CT 06520 USA
[4] CMD, Janssen Res Fdn, B-2350 Vosselaar, Belgium
关键词
D O I
10.1021/jm9804174
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Monte Carlo (MC) simulations in combination with a linear response approach were used to estimate the free energies of binding for a series of 12 TIBO nonnucleoside inhibitors of HIV-1 reverse transcriptase. Separate correlations were made for the R-6 and S-6 absolute conformations of the inhibitors, as well as for the analogous N6-monoprotonated species. Models based upon the neutral unbound inhibitors produced overall better fits to experimental values than did those using the protonated unbound inhibitors, with only slight differences between the neutral R-6 and S-6 cases. The best results were obtained with a three-parameter linear response equation containing van der Waals (alpha), electrostatic (beta), and solvent accessible surface area (SASA, gamma) terms. The averaged (R-6 and S-6) rms error was approximately 0.88 kcal/mol for the observed range of 4.06 kcal/mol in inhibitor activities. The averaged values of alpha, beta, and gamma mere -0.150, 0.114, and 0.0286, respectively. Omission of the alpha term gave beta 0.152 and gamma 0.022 with a rms of 0.92. The unweighted van der Waals components were found to be highly attractive but failed to correlate well across the series of inhibitors. Contrastingly, while the electrostatic components are all repulsive, they show a direct correlation with inhibitor activity as measured by Delta G(binding). The role of gamma is primarily to produce an overall negative binding energy, and it can effectively be replaced with a negative constant. During the MC simulations of the unbound solvated inhibitors, the R-6 and S-6 absolute conformations do not interconvert; due to the formation of a favorable hydrogen bond to solvent. In the complex, however, interconversion of these conformations of the inhibitor is observed during the course of the simulations, a phenomenon which is apparently not observed in the crystalline state of the complex. Hydrogen bonding of the inhibitor to the backbone NH of K101 and the lack of such an interaction with the C=O of K101 or with solvent correlate with enhanced activity, as does the ability to assume a number of different orientations of the inhibitor dimethylallyl moiety with respect to residues Y181 and Y188 while retaining contact with W229. Overall, the use of a combination of MC simulation with a linear response method shows promise as a relatively rapid means of estimating inhibitor activities. This approach should be useful in the preliminary evaluation of potential modifications to known inhibitors to enhance activity.
引用
收藏
页码:5272 / 5286
页数:15
相关论文
共 50 条
  • [11] HIV-1 reverse transcriptase inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (03) : 122 - 122
  • [12] HIV-1 reverse transcriptase inhibitors
    Yazan El Safadi
    Valérie Vivet-Boudou
    Roland Marquet
    Applied Microbiology and Biotechnology, 2007, 75 : 723 - 737
  • [13] Assessment of Nonnucleoside Inhibitors Binding to HIV-1 Reverse Transcriptase Using HYDE Scoring
    Paneth, Agata
    Plonka, Wojciech
    Paneth, Piotr
    PHARMACEUTICALS, 2019, 12 (02)
  • [14] Combining docking, molecular dynamics and the linear interaction energy method to predict binding modes and affinities for non-nucleoside inhibitors to HIV-1 reverse transcriptase
    Carlsson, Jens
    Boukharta, Lars
    Aqvist, Johan
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (09) : 2648 - 2656
  • [15] Linear-response study on the binding affinity of non-nucleoside RT inhibitors with HIV-1 reverse transcriptase
    Sun, GY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2611 - U2611
  • [16] Structure based activity prediction of HIV-1 reverse transcriptase inhibitors
    de Jonge, MR
    Koymans, LMH
    Vinkers, HM
    Daeyaert, FFD
    Heeres, J
    Lewi, PJ
    Janssen, PAJ
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 2176 - 2183
  • [17] Novel HIV-1 reverse transcriptase inhibitors
    Jochmans, Dirk
    VIRUS RESEARCH, 2008, 134 (1-2) : 171 - 185
  • [18] Effects of the K103N mutation on the binding of sustiva analogs to HIV-1 reverse transcriptase based on Monte Carlo simulations.
    Udier-Blagovic, M
    Tirado-Rives, J
    Jorgensen, WL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U763 - U763
  • [19] An overview on HIV-1 reverse transcriptase inhibitors
    Ravichandran, Shalini
    Veerasamy, Ravichandran
    Raman, Saraswathi
    Krishnan, Palamadai Neelakandam
    Agrawal, Ram Kishore
    DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES, 2008, 3 (04) : 171 - 187
  • [20] COMP 197-Combining docking, molecular dynamics and the linear interaction energy method to predict binding modes and affinities for nonnucleoside inhibitors to HIV-1 reverse transcriptase
    Carlsson, Jens
    Persson, Lars
    Aqvist, Johan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236